Representational difference analysis (RDA) is a powerful technique for cloning the differences between genomes, and has recently been adapted for cloning differentially expressed genes. RDA, like other PCRbased differential screening methods, is prone to the production of false positives. We have identified a major source of false positives in RDA of cDNA and have introduced improvements which minimise their production. These modifications also significantly increase sensitivity, allowing for the isolation of rare differential transcripts from nanogram amounts of mRNA.
In the absence of informative genetic mutants, efforts in cloning developmentally important genes have often focused on identification and cloning of transcripts based solely on their expression profiles. However, traditional approaches to cloning differentially expressed genes, such as subtractive hybridisation, have required large amounts of RNA making them unsuitable for studies of embryonic development. In recent years several PCR-based differential screening methods (1-3) have circumvented the need for large amounts of starting material. Techniques such as differential display can be performed with sub-microgram amounts of total RNA. Early optimism about the new techniques has been dampened by reports of a high incidence of false positives and poor representation of rare mRNAs (4, 5) . Given the apparent widespread use of these methods, surprisingly few genes have been cloned from embryonic material.
In this study we assessed the ability of representational difference analysis (RDA) of cDNA in detecting rare transcripts. RDA was performed as previously described (6,7) with the following exceptions: (i) 100-150 ng of poly A+ RNA was used in the cDNA synthesis; (ii) digested and excess adaptors were removed by washing the cDNA on Microcon 30 filters (Amicon®); and (iii) 25 µg of driver cDNA was used in the hybridisations while maintaining the previously described driver:tester ratios (a detailed protocol is available from the authors).
In this experiment, four tester samples were produced using 10 µg total RNA from 6.5 day chick embryo brain spiked with varying amounts of a known transcript. A polyadenylated in vitro transcript was generated from a 1.3 kb fragment of the neomycin resistance gene cloned into the pSp64-polyA+ vector (Promega®) (8) . The in vitro transcript was added to a final concentration of: 0.5% of mRNA in sample 1; 0.05% in sample 2; 0.005% in sample 3; 0.0005% in sample 4, assuming poly A+ RNA to be 1.5% of total RNA. Poly A+ RNA was purified from spiked total RNA using oligo-dT magnetic beads (Dynal®) and cDNA was synthesised from the eluent. The resulting double stranded cDNA was digested with DpnII and ligated to R Bgl adaptors (a 24mer annealed to a 12mer) (6). The 1.3 kb neo fragment produces two internal DpnII fragments of 311 and 376 bp and a number of very small fragments (>80 bp). With the addition of RDA adaptors the expected fragments were 359 and 424 bp, respectively. The driver for RDA was produced from unspiked 6.5 day chick embryo brain RNA (from the same source as the testers). The only difference between the four testers and the driver is the presence of the spiked neo transcript in each tester, consequently the two DpnII fragments (359 and 424 bp) from the neo cDNA were the only end products expected after subtraction. Figure 1A shows the results after two rounds of subtractive hybridisation and PCR enrichment (difference product 2 or DP2), while Figure 1B shows the results after three rounds (difference product 3 or DP3). Unexpectedly, a range of bands of varying size was detected. However, the highest band corresponds to the 359 bp band; one of the two expected. Southern analysis of the DP3 gel confirms the identity of the expected neo band (Fig. 1C) . This result shows the exquisite sensitivity of RDA in enriching for cDNA fragments unique to the tester even when those fragments are generated from a transcript present at one copy per cell (sample 4). While RDA is shown to be very sensitive in this experiment, the presence of several unexpected bands in DP2 and DP3 indicates a propensity for RDA producing false positives.
To characterise the RDA products from this experiment, the entire DP3 of sample 4 was purified and cloned into a plasmid vector. Fourteen random recombinant clones were isolated and the inserts sequenced. None of the 14 clones contained either of the expected neo fragments. All 14, however, contained different cDNA inserts flanked by a varying array of RDA adaptors in tandem. Interestingly, the sites of ligation between the adaptor arrays and the cDNAs lacked DpnII restriction sites. A schematic of these ligation products is shown in Figure 2 . The sequence data from these clones suggested that these products must be formed by blunt-end ligation of cDNAs to adaptors. Such a ligation could result from an adaptor composed of failed products in the oligonucleotide preps. Failed products are generally truncated at their 5′ ends. An 8 nt failed product in the 12mer synthesis would * To whom correspondence should be addressed. Tel: +61 3 9345 6607; Fax: +61 3 9345 6000; Email: oneill@cryptic.rch.unimelb.edu.au lack the terminal GATC and, once annealled to the 24mer, would result in a blunt-ended adaptor. Such events would result in cDNAs that retain PCR primer binding sites even after DpnII digestion. These 'illegitimate' ligation events would involve random blunt-end cDNA fragments, and since failed products are presumably rare in our oligo preps, a random assortment of amplifiable cDNA fragments would be generated that would behave, effectively, as tester unique fragments.
In an attempt to correct this problem we repeated the same experiment using reverse phase HPLC purified oligonucleotides (Bresatec®, Australia). The results of RDA using HPLC purified primers are shown in Figure 3 . As can be seen, there was a remarkable improvement in clarity, sensitivity and fidelity of RDA. Indeed, as shown by DP2 in Figure 3A , only two rounds of RDA resulted in the two expected bands (359 and 424 bp) with virtually no background. Figure 3B shows increased clarity of bands in sample 1, but a slight decrease in yield for all samples in DP3. However, by increasing the final PCR from 22 cycles (Fig. 3B) to 25 cycles (Fig. 3C) we significantly improved the yield of the two neo fragments in sample 4 (0.0005% of message). Successive RDA trials using HPLC purified primers on RNA from various embryonic sources have confirmed these results. These experiments demonstrate that RDA, conducted with HPLC purified adaptors, is sufficiently sensitive to allow the cloning of rare differentially expressed transcripts.
